Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel plus thalidomide for refractory metastatic osteosarcoma
ChiCTR-TNC-13003013Phase 2Completed
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel and thalidomide in osteosarcoma (OS), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Tumor response, Progression-free time and 1 more. Started Nov 2012; status: completed.
02
Drugs
paclitaxelthalidomide
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on ChiCTR-TNC-13003013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-13003013.